GTG Global Collaborations and Innovation Update
26 mars 2024 08h00 HE
|
Genetic Technologies Ltd
GTG Global Collaborations and Innovation Update
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
25 mars 2024 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, March 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, “Company”, “GENE”), a global leader in guideline-driven genomics-based testing in health, wellness...
GTG to launch U.S. Customer Digital Media Sales Campaign
28 févr. 2024 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”, “GTG”), is pleased to announce the launch of a wide-reaching customer – targeted...
Global Paternity & Relationship Testing Services Market Forecast to Skyrocket by 2027 with Advances in Direct-to-Consumer Genetic Technologies
26 févr. 2024 03h44 HE
|
Research and Markets
Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Paternity & Relationship Testing Services. Global Market Forecasts for Applications and Technologies with Executive and Consultant Guides. 2023 to...
Launching our most comprehensive test and expanding into new global markets
31 janv. 2024 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE), is at the forefront in personalised predictive genomics, reshaping the healthcare landscape with...
Global Optogenetics Market Report 2024-2033: Emerging Trends in Tools & Technologies, Pharma Collaborations, Drug Discovery & Development Integration, and Non-Neural Cell Type Applications
18 janv. 2024 06h53 HE
|
Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Optogenetics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global optogenetics market has grown rapidly in...
GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
14 déc. 2023 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies (GTG) is proud to provide details of a series of recent transformative initiatives. Our commitment to advancing early...
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
12 déc. 2023 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and...
Global Gene Therapy Market Poised for Remarkable 9.26% CAGR, Expected to Reach USD 10.13 Billion by 2028
31 oct. 2023 08h48 HE
|
Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's...
Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial
30 oct. 2023 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, ”Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health,...